Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for April 2010. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Risk Factors for Physician Misconduct Identified
WEDNESDAY, April 28 (HealthDay News) -- Doctors who are male, are from lower socioeconomic groups or had academic difficulties in medical school may be at increased risk of professional misconduct, according to a study published online April 27 in BMJ.
FDA Changes Medical Device Advisory Committee Process
TUESDAY, April 27 (HealthDay News) -- Because of the increasing number of medical device advisory panel meetings in recent years, the U.S. Food and Drug Administration is changing the way expert panels review and discuss information during public hearings on devices that are being reviewed for premarket approval.
Interruptions Increase Medication Errors by Nurses
TUESDAY, April 27 (HealthDay News) -- Nurses who are interrupted in the process of preparing and administering medications are more likely to make an error, with error severity increasing with the number of interruptions, according to a study in the April 26 issue of the Archives of Internal Medicine.
Financial Ties Negatively Affect Perceptions of Research Quality
TUESDAY, April 27 (HealthDay News) -- Disclosure of financial ties to industry influences patients', physicians', and research participants' beliefs about the quality of research evidence, according to a review published in the April 26 issue of the Archives of Internal Medicine.
Vitamin D Deficiency Linked to Progression to Active TB
THURSDAY, April 15 (HealthDay News) -- Low vitamin D levels are associated with progression to active tuberculosis in healthy household contacts of tuberculosis patients, according to a study published online April 14 in Emerging Infectious Diseases. Another study in the same journal found a high prevalence of latent tuberculosis infection among drug users, female sex workers, and homeless individuals in Tijuana, Mexico.
Study Shows How Antibody Class Inhibits HIV Infection
WEDNESDAY, April 7 (HealthDay News) -- Naturally occurring antibodies that can block a method of HIV entry into cells point to a possible new approach for designing HIV vaccines, according to research published online April 5 in the Journal of Experimental Medicine.
Copyright © 2010 ScoutNews, LLC. All rights reserved.
|Previous: April 2010 Briefing - Gastroenterology||Next: April 2010 Briefing - Infectious Disease|
Reader comments on this article are listed below. Review our comments policy.